Sen-Jam Pharmaceutical Planning to Trial Oral COVID Therapy
/PRNewswire/ -- Excessive inflammation is a hallmark of severe COVID-19. When confronted with the virus, the immune system can enter a hyper-inflammatory state...
Source: prnewswire.com
Stay updated with breaking news from Jam Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Excessive inflammation is a hallmark of severe COVID-19. When confronted with the virus, the immune system can enter a hyper-inflammatory state...